Novartis AG (NOVN.VX: Quote, Profile, Research) shares gained more than two percent on Monday on hopes it would boost 2003 profits after winning a patent case over copycat forms of GlaxoSmithKline Plc’s (GSK.L: Quote, Profile, Research) antibiotic Augmentin.
